Navigation Links
Dendreon Announces Pricing of Common Stock Offering
Date:12/10/2009

and Exchange Commission (the "SEC"). Copies of the prospectus supplement and related base prospectus for this offering, when available, may be obtained by contacting: J.P. Morgan Securities Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by calling 1-866-803-9204; or Deutsche Bank Securities Inc., Prospectus Department, Harborside Financial Center, 100 Plaza One, Jersey City, New Jersey 07311-3988, or by calling 1-800-503-4611. An electronic copy of the prospectus supplement and related base prospectus for the offering will also be available on the SEC's website, www.sec.gov.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The offering of these securities will be made only by means of a prospectus supplement and accompanying base prospectus. The securities being offered have not been approved or disapproved by any regulatory authority, nor has any such authority passed upon the accuracy or adequacy of the registration statement or the prospectus contained therein.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics. Dendreon applies its expertise in antigen identification, engineering and cell processing to produce ACI product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets TRPM8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. Dendreon has its headquarters in Seattle, Washington, and is traded on the Nasdaq Global Market under the symbol DNDN.

This news release contains forward-looking statements that are subject to risks
'/>"/>

SOURCE Dendreon Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dendreon Appoints Hans Bishop as Chief Operating Officer
2. Dendreon Announces Proposed Public Offering of Common Stock
3. Dendreon Receives FDA Acknowledgement of Complete Response
4. Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE Commercialization
5. Dendreon Completes Submission of Biologics License Application for PROVENGE
6. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
7. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
8. Dendreon Announces Analyst Day Webcast Presentation to be Held on September 24, 2009
9. Dendreon Reports Second Quarter 2009 Financial Results
10. Dendreon Signs Lease for New Manufacturing Facility in Atlanta
11. Dendreon to Hold Conference Call on Tuesday, August 11, 2009 at 11:30 AM ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... January 22, 2015 Eckert & Ziegler ... Spectrometry (AMS) services to the pharmaceutical and biotech industry, ... the company in the position of Director of Science ... broad and valuable experience in drug metabolism and bioanalysis ...
(Date:1/22/2015)... GEA Niro Soavi the leader in ... the PandaPLUS 2000, which is ideal for new applications ... cell disruption . This compact laboratory homogenizer is the ... food, food additives and ingredients as well as for ...
(Date:1/22/2015)... The laboratory information management systems market is a ... technological advancements due to factors such as rising pressure ... healthcare systems, and increasing government support for adoption of ... players in the market focus on technological advancements to ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Pipette.com has ... to their comprehensive portfolio of Eppendorf products. , ... to purchase a Centrifuge 5424/5424 R and receive the ... either Eppendorf Research plus or Eppendorf Reference 2 ...
Breaking Biology Technology:Eckert & Ziegler Vitalea Science appoints Mark Seymour, PhD as Director of Science & Technology 2Eckert & Ziegler Vitalea Science appoints Mark Seymour, PhD as Director of Science & Technology 3GEA Niro Soavi Announces the PandaPLUS 2000 Homogenizer for Processing New Applications for Nanoemulsions and Cell Disruption 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 4Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2
... HEIGHTS, N.J., Feb. 16, 2011 Zymes LLC is ... two-year $476,000 grant from the Michael J. Fox Foundation,s ... titled, "Evaluation of the Neuroprotectivity Ability of Zymes, ... disease): Preclinical Validation and Dose Optimizations for Clinical Study" ...
... Pa., Feb. 16, 2011 Tengion, Inc. (Nasdaq: ... it has been engaged in negotiations with a publicly traded ... merger.  As a result of the recent increases in the ... acquirer has terminated merger negotiations. As has ...
... An important milestone toward the realization of a large-scale quantum ... quantum control of light, were accomplished by a team of ... The study, published in the Feb. 7 issue of ... Zhejiang University, China, and NEC Corporation, Japan. The experimental effort ...
Cached Biology Technology:Michael J. Fox Foundation Awards Grant to Zymes LLC 2Tengion Addresses Recent Trading Activity in its Common Stock 2International team of scientists says it's high 'NOON' for microwave photons 2
(Date:12/19/2014)... Dec. 18, 2014 Research and Markets ( ... "iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire ... http://photos.prnewswire.com/prnh/20130307/600769 Following ... the fingerprint reading feature with the iPhone 5S. It ...
(Date:12/17/2014)... BELVOIR, Va. , Dec. 15, 2014 The ... it easier to detect and prevent counterfeit microcircuits from ... agency started performing an in-house microcircuit anti-counterfeit initiative dubbed ... purchased microcircuits while increasing their reliability throughout the supply ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... "Global Facial Recognition Market 2015-2019" report to ... Facial recognition is a technology used for ... overall facial feature of a person such as nose, ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... Penn State food scientists have shown that the amount ... the toasty aroma developed by oats and might be ... products. , Polyphenols are a large family of naturally ... wide variety of health benefits. Flavonoids and some ...
... that controls plant growth may help explain why human ... of scientists. , ,Researchers from Purdue University and ... time that proteins similar to multi-drug resistant proteins in ... Purdue plant cell biologist Angus Murphy. Because plant proteins ...
... Medicine report in a new study that they have identified ... the fatty insulation around nerve cells that ensures swift and ... the September 1, 2005, issue of the journal Neuron, may ... as multiple sclerosis, which are associated with damage to myelin. ...
Cached Biology News:Toasty oat aroma influenced by presence of health-linked polyphenols 2Toasty oat aroma influenced by presence of health-linked polyphenols 3Plant gene related to cancer treatment may foster new oncology drugs 2Plant gene related to cancer treatment may foster new oncology drugs 3Scientists discover the molecular switch for nerve cells' insulating jelly rolls 2
... Agarose-HR High Resolution - ... from 50 to 1000 ... for sizing PCR fragments, ... by restriction enzyme digestion, ...
... Clone/PAD: ZMD.358. Immunogen: Synthetic ... region of human mouse and ... with human and mouse LRP5 ... (positive controls: mouse LRP5-pSEC-tag-transfected 293T ...
Replacement Parts for Electrophoresis Apparatus...
...
Biology Products: